✦ LIBER ✦

Octreotide for the Treatment of Hypoglycemia After Insulin Glargine Overdose

✍ Scribed by Groth, Christine M.; Banzon, Eleanor R.

Book ID: 122722045
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 135 KB
Volume: 45
Category: Article
ISSN: 0736-4679
DOI: 10.1016/j.jemermed.2012.11.099

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The effectiveness of various doses of oc

The effectiveness of various doses of octreotide for sulfonylurea-induced hypoglycemia after overdose

✍ Mehmet Gul; Basar Cander; Sadik Girisgin; Murat Ayan; Sedat Kocak; Ali Unlu 📂 Article 📅 2006 🏛 Springer Healthcare Communications 🌐 English ⚖ 187 KB

PDB29 HEALTH ECONOMIC EVALUATION OF INSU

PDB29 HEALTH ECONOMIC EVALUATION OF INSULIN GLARGINE FOR THE TREATMENT OF TYPE-1 AND TYPE-2 DIABETES

✍ M Thompson; L Sauriol; D Grima 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB

Patient-reported outcomes in a trial of

Patient-reported outcomes in a trial of exenatide and insulin glargine for the treatment of type 2 diabetes

✍ Kristina Secnik Boye; Louis S Matza; Alan Oglesby; Karen Malley; Sunny Kim; Risa 📂 Article 📅 2006 🏛 BioMed Central 🌐 English ⚖ 544 KB

A randomized trial of adding insulin gla

A randomized trial of adding insulin glargine vs. avoidance of insulin in people with Type 2 diabetes on either no oral glucose-lowering agents or submaximal doses of metformin and/or sulphonylureas. The Canadian INSIGHT (Implementing New Strategies with Insulin Glargine for Hyperglycaemia Treatment) Study

✍ H. C. Gerstein; J.-F. Yale; S. B. Harris; M. Issa; J. A. Stewart; E. Dempsey 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 180 KB

Safety and efficacy of glargine compared

Safety and efficacy of glargine compared with NPH insulin for the treatment of Type 2 diabetes: a meta-analysis of randomized controlled trials

✍ L. A. Bazzano; L. J. Lee; L. Shi; K. Reynolds; J. A. Jackson; V. Fonseca 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 590 KB

PDB51 COST-EFFECTIVENESS OF EXENATIDE VE

PDB51 COST-EFFECTIVENESS OF EXENATIDE VERSUS INSULIN GLARGINE AND VERSUS BIPHASIC INSULIN ASPART FOR THE TREATMENT OF TYPE 2 DIABETES IN PORTUGAL: A LONG-TERM HEALTH ECONOMIC ANALYSIS

✍ JL Palmer; CG Pinto; R Duarte; L Miguel; Z Gregor 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB